Skip to main content
SpringerLink
Log in

Die internistische Therapie des metastasierenden Mammakarzinoms

  • Conference paper
Therapie des Mammakarzinoms

Zusammenfassung

Beim metastasierenden Mammakarzinom stehen zwei etablierte Modalitäten der internistischen Therapie zur Verfügung: die Hormontherapie und die zytostatische Chemotherapie. Die Immunotherapie befindet sich noch im experimentellen Stadium und hat keinen gesicherten Platz in der Therapie des Mammakarzinoms.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Ahmann D. L., O’Connell J. O., Haan R. G. et al. (1977) An evaluation of early or delayed adjuvant chemotherapy in premenopausal patients with advanced breast cancer undergoing oophorectomy. New Engl. J. Med. 297, 356–360

    Article  PubMed  CAS  Google Scholar 

  2. Band P. R., Tormey, D. C. and Bauer M. for the ECOG (1977): Induction chemotherapy and maintenance chemo-hormontherapy in metastatic breast cancer. Proc. Am. Ass. Cancer Res. 18:228, 1977

    Google Scholar 

  3. Beex L., Pieters G., Smals A., Koenders A., Benraad T., Kloppenborg P. (1981) Tamoxifen versus ethinyl estradiol in the treatment of postmenopausal women with advanced breast cancer. Cancer Treat. Rep. 65: 179–185

    PubMed  CAS  Google Scholar 

  4. Bertuzzi A., Daidone M. G., Di Fronzo G., Silvestrini R. (1981): Relationship among estrogen receptors, proliferative activity and menopausal status in breast cancer. Breast Cancer Res. Treat. 1:253–262

    Article  PubMed  CAS  Google Scholar 

  5. Blumenschein G., Cardenas J., Freireich E. and Gottlieb J. (1974): FAC chemotherapy for breast cancer. Proc. Am. Ass. Cancer Res. 15: 193

    Google Scholar 

  6. Brambilla C., Valagussa P., Bonadonna G. (1978): Sequential combination chemotherapy in advanced breast cancer. Cancer Chemother. Pharmacol. 1:35–39

    CAS  Google Scholar 

  7. Broder L. E. and Tormey D. C. (1974): Combination chemotherapy of carcinoma of the breast. Cancer Treat. Rev. 1:183–203

    Article  Google Scholar 

  8. Brunner K. W., Sonntag R. W., Martz G., Senn H. J., Obrecht P. and Alberto P. (1975): A controlled study in the use of combined drug therapy for metastatic breast cancer. Cancer 36:1208–1219

    Article  PubMed  CAS  Google Scholar 

  9. Brunner K. W., Sonntag R.W., Alberto P., Senn H. J., Martz G. and Obrecht P. (1977): Combined chemo-and hormonal therapy in advanced breast cancer. Cancer 39:2923–2933

    Article  PubMed  CAS  Google Scholar 

  10. Brunner K. W. (1978): Present status of combination chemotherapy in advanced breast cancer. In: Application of Cancer Chemotherapy. Antibiotics Chemother. Vol 24, Karger Basel, 173–188

    CAS  Google Scholar 

  11. Brunner K. W., Cavalli F. (1981): Combination endocrine/cytotoxic therapy in breast cancer. In Stoll B. A. (Hrsg.): Hormonal management in endocrine-related cancer. Lloyd-Luke Med. Books, Ltd., London

    Google Scholar 

  12. Bull J. M., Tormey D. C., Li S. H. et al. (1978): A randomized trial of Adriamycin versus Methotrexate in combination drug therapy. Cancer 41:1649–1657

    Article  PubMed  CAS  Google Scholar 

  13. Canellos G. P., Pocock S. J., Taylor S. G. et al. (1976): Combination chemotherapy for metastatic breast carcinoma. Cancer 38: 1882–1886

    Article  PubMed  CAS  Google Scholar 

  14. Carmo-Pereira J., Costa F. L., Henriques E. (1981): Chemotherapy of advanced breast cancer. A randomized trial of vincristine, adriamycin and cyclophosphamide (VAC) versus cyclophosphamide, Methotrexate, 5-fluorouracil and prednisone (CMFP). Cancer 48:1517–1521

    Article  PubMed  CAS  Google Scholar 

  15. Carter S. K. (1981): The interpretation of trials: combined hormonal therapy and chemotherapy in disseminated breast cancer. Breast Cancer Res. Treat. 1, 43–52

    CAS  Google Scholar 

  16. Carter S. K. (1976): Chemotherapy of breast cancer: current status; in Breast Cancer, trends in research and treatment, 196–215, Raven Press, New York

    Google Scholar 

  17. Castiglione M., Cavalli F. (1980): Ergebnisse einer Pilotstudie mit hochdosiertem Medroxyprogesteron-Azetat in der Behandlung des metastasierenden Mammakarzinoms. Schweiz. Med. Wochenschr. 110: 1073–1076

    CAS  Google Scholar 

  18. Cavalli F., Beer M., Martz G., Jungi W. F., Alberto P., Obrecht J. P., Mermillod B., Brunner K. W. (1982): Gleichzeitige oder sequentielle Hormono-Chemotherapie sowie Vergleich verschiedener Polychemotherapien in der Behandlung des metastasierenden Mammakarzinoms. Schweiz. Med. Wschr. 112:774–783

    PubMed  CAS  Google Scholar 

  19. Cavalli F., Pedrazzini A, Martz G. et al. (fir die SAKK) (1983): Randomized trial of 3 different regimens of combination chemotherapy in patients receiving simultaneously a hormonal treatment for advanced breast cancer. Akzeptiert zur Publikation im: European Journal of Cancer 1983

    Google Scholar 

  20. Cavalli F., Beer M., Martz G., Jungi W. F., Alberto O., Obrecht J. P., Mermillod B., Brunner K. W. (1983): Concurrent or sequential use of cytotoxic chemotherapy and hormone treatment in advanced breast cancer: report of the Swiss Group for Clinical Cancer Research. British Med. J. 286:5–8

    Article  CAS  Google Scholar 

  21. Cocconi G., Cascinelli E. et al. (im Druck): CMF and tamoxifene versus CMF alone in advanced breast cancer. Cancer (Philad.)

    Google Scholar 

  22. Cooper R. (1969): Combination chemotherapy in hormone resistant breast cancer. Proc. Am. Ass. Cancer Res. 10:15

    Google Scholar 

  23. Cummings F. J., Gelman R., Horton J. and Calman K. (for the ECOG) (1982): Compari- son of CMFP with CAF in patients with metastatic breast cancer. Abstract. Proceedings. International Congress, Seattle

    Google Scholar 

  24. De Jager R., Kaufman R., Ochoa M. and Krakoff I. H. (1975): Chemotherapy of advanced breast cancer with a combination of cytoxan, adriamycin and 5-FU (CAF). Proc. Am. Ass. Cancer Res. 16:273

    Google Scholar 

  25. De Lena M, De Palo G. M., Bonadonna G., Beretta G. and Bajetta E. (1973): Terapia del carcinoma mammario metastatizzato con ciclofosfamide, methotrexate, vincristina e fluorouracile. Tumor 59:11–24

    Google Scholar 

  26. Fabian C., Sternson L., Barnett M. (1980): Clinical pharmacology of tamoxifen in patients with breast cancer: Comparison of traditional and loading dose schedules. Cancer Treat. Rep. 64:765–773

    PubMed  CAS  Google Scholar 

  27. Falkson G., Falkson H. C., Glidewell O., Weinberg V., Leone L. and Holland J. F. (1979): Improved remission rates and remission duration in young women with metastatic breast cancer following combined oophorectomy and chemotherapy. A study by Cancer and Leukemia Group B. Cancer (Philad.) 43, 2215–2222

    Article  CAS  Google Scholar 

  28. Greenspan E. (1966): Combination cytotoxic chemotherapy in advanced disseminated breast cancer. J. Mt. Sinai Hosp. 33: 1–27

    CAS  Google Scholar 

  29. Harvey H. A., Lipton A., White D. S. et al. (1982): Cross-over comparison of Tamoxifen and Aminoglutethimide in advanced breast cancer. Proc. ASCO 1:79

    Google Scholar 

  30. Henderson I. C., Canellos G.P. (1980): Cancer of the breast. The past decade. N. Engl. J. Med. 302: 17–30, 78–90

    Article  PubMed  CAS  Google Scholar 

  31. Hoogstraten B. (1982): The role of Tamoxifen in predicting response to ovarian ablation in patients with recurrent breast cancer. Proc. ASCO 1:72

    Google Scholar 

  32. Ingle J. N., Ahmann D. L., Green S. J. et al. (1981): Randomized clinical trial of diethylstilboestrol versus Tamoxifen in postmenopausal women with advanced breast cancer. N. Engl. J. Med. 304:16–21

    Article  PubMed  CAS  Google Scholar 

  33. Jordan V. C., Rowsby L., Dix C. J. et al. (1978): Dose-related effects of nonsteroidal anti-estrogens and oestrogens on the measurement of cytoplasmic oestrogen receptors in the rat and mouse uterus. J. Endocrinol. 78:71–81

    Article  PubMed  CAS  Google Scholar 

  34. Klaassen D. J., Rapp E. E. and Hirte W. E. (1976): Response to medroxyprogesterone acetate (NSC 26386) as a secondary hormone therapy for metastatic breast cancer in postmenopausal women. Cancer Treat. Rep. 60: 251

    PubMed  CAS  Google Scholar 

  35. Lippmann M. E., Tormey D. C., Cassidy J. and Edwards B. K. (1981): A randomized trial of tamoxifen (TAM) versus tamoxifen plus fluoxymesterone (FLU) in metastatic breast cancer. Proc. Amer. Soc. Clin. Oncol.: 22:441

    Google Scholar 

  36. Lloyd R. E., Jones S. E. and Salmon S. E. and Southwest Oncology Group Members (1975): Phase II trial of adriamycin and cyclophosphamide: a Southwest Group Oncology Pilot Study. Proc. Am. Ass. Cancer Res. 16:265

    Google Scholar 

  37. Manni A, Trujillo J. E., Pearson O. H. (1980): Sequential use of endocrine therapy and chemotherapy for metastatic breast cancer: effects on survival. Cancer Treat. Rep. 64, 111–116

    PubMed  CAS  Google Scholar 

  38. Manni A., Arafah B., Pearson O. H. (1980): Estrogen and progesterone receptors in the prediction of response of breast cancer to endocrine therapy. Cancer 46:2838–2841

    Article  PubMed  CAS  Google Scholar 

  39. McCarthy K., Barton T. K., Fetter B. F. et al. (1980): Correlation of estrogen and progesterone receptors with histologic differentiation in mammary carcinoma. Cancer 46:2851–2858

    Article  Google Scholar 

  40. McGuire W. L. (1978): Hormone receptors: their role in predicting prognosis and response to endocrine therapy. Semin. Oncol. 5:428–433

    PubMed  CAS  Google Scholar 

  41. Muggia F. M., Cassileth P. A., Ochoa M. Jr., Flatow F. A., Gellhorn A., Hyman G. A. (1968): Treatment of breast cancer with medroxyprogesterone acetate. Ann. Intern. Med. 63:328

    Google Scholar 

  42. Mouridsen H. T., Ellemann K., Mattson W. et al. (1979): Therapeutic effect of Tamoxifen versus Tamoxifen combined with Medroxyprogesterone acetate in advanced breast cancer in postmenopausal women. Cancer Treat. Rep. 63:171

    PubMed  CAS  Google Scholar 

  43. Muss H. B., White D. R., Richards F. et al. (1978): Adriamycin versus Methotrexate in five drug combination chemotherapy for advanced breast cancer. Cancer 42: 2141–2148

    Article  PubMed  CAS  Google Scholar 

  44. Namer M., Lalanne C. and Beaulieu E. E. (1980): Increase of progesterone receptors by Tamoxifen as a hormonal challenge test in breast cancer. Cancer Res. 40:1750

    PubMed  CAS  Google Scholar 

  45. Patterson J. S. and Battersby L. A. (1980): Tamoxifen: An overview of recent studies in the field of oncology. Cancer Treat. Rep. 64:775–778

    PubMed  CAS  Google Scholar 

  46. Pannuti F., Martoni A., Lenaz C. R., Piana E. and Nanni P. (1978): A possible new approach to the treatment of metastatic breast cancer: massive doses of medroxyprogesterone acetate. Cancer Treat. Rep. 62: 504

    Google Scholar 

  47. Pellegrini A., Massida B., Mascha V. et al. (1981): Ethinyl estradiol and Medroxyprogesterone treatment in advanced breast cancer. A pilot study. Cancer Treat. Rep. 65:135–136

    CAS  Google Scholar 

  48. Pritchard K. I., Thomson D. B., Meakin J. W. et al. (1981): The role of Tamoxifen in premenopausal women with metastatic carcinoma of the breast. Ann. Update Proc. AACR ASCO 22: 436

    Google Scholar 

  49. Robustelli Della Cuna G., Calciati A., Bernardo Strada M. R., Bumma C. and Campio L. (1978): High doses medroxyprogesterone acetate (MPA) treatment in metastatic carcinoma of the breast. A dose response evaluation. Tumori 64:143

    Google Scholar 

  50. Rosner D. (1982): Optimal sequential sçstemic therapy for increased survival in metastatic breast cancer. Abstract. Proceedings 13 International Congress, Seattle

    Google Scholar 

  51. Ross M. B., Buzdar A. U., Blumenschein G. R. (1982): Treatment of advanced breast cancer with megestrol acetate after therapy with tamoxifen. Cancer 49:413–417

    Article  PubMed  CAS  Google Scholar 

  52. Rubens R. D., Begent R. H. J., Knight R. K., Sexton S. A. and Hayward J. L. (1978): Combined cytotoxic and progestogen therapy for advanced breast cancer. Cancer 42: 1680–1686

    Article  PubMed  CAS  Google Scholar 

  53. Santen R. J., Worgul T. J., Samojlik E. et al. (1981): A randomised trial comparing surgical adrenalectomy with aminoglutethimide plus hydrocortisone in women with advanced breast cancer. N. Engl. J. Med. 305:545–551

    Article  PubMed  CAS  Google Scholar 

  54. Smalley R. V., Murphy S., Chan Y. K. and Huguley C. M. (1973): Comparison of two five-drug reimens vs. sequential chemotherapy in metastatic breast carcinoma. Cancer Che-mother. Rep. 57: 110

    Google Scholar 

  55. Smalley R. and Bornstein R. (1975): C-A-F treatment of metastatic breast carcinoma. Proc. Am. Ass. Cancer Res. 16:265

    Google Scholar 

  56. Smalley R. V., Murphy S., Huguley C. M. et al. (1976): Combination versus sequential five-drug chemotherapy in metastatic breast cancer. Cancer Res. 36:3911–3916

    PubMed  CAS  Google Scholar 

  57. Smalley R. V., Carpenter J., Bartolucci A. et al. (1977): Comparison of cyclophosphamide, methotrexate, 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer. Cancer 40: 625–632

    Article  PubMed  CAS  Google Scholar 

  58. Smith I. E., Harris A. L., Morgan M. et al. (1981): Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomised cross-over trial. Br. Med. J. 283:1432–1434

    Article  CAS  Google Scholar 

  59. Smith I. E., Harris A. L., Morgan M. W. et al. (1982): Tamoxifen versus Aminoglutethimide versus combination TAM+ AG in advanced breast carcinoma. Proc. ASCO 1:87

    Google Scholar 

  60. Stewart J. F., King R., Hayward J. L. and Rubens R. D. (1981): The value of repeating steroid receptor analysis in the endocrine treatment of breast cancer. Am. Soc. Clin. Oncology 23:74

    Google Scholar 

  61. Tormey D., Carbone P. and Band P. (1977): Breast cancer survival in single and combination chemotherapy trials since 1968. Proc. Am. Ass. Cancer Res. 18:64

    Google Scholar 

  62. Tormey D. C., Gelman R., Band P. and Carbone P. for the ECOG (1980): Comparison of single to alternating combination therapy in metastatic breast cancer. Am. Ass. Cancer Res.: 171 (Abstract)

    Google Scholar 

  63. Wagner R. K., Parl F. F. (1980): The histopathological evaluation of human breast cancers in correlation with estrogen receptor values. Cancer 46:362–367

    Article  PubMed  Google Scholar 

  64. Young R. C., Lippman M., DeVita T. V., Bull J. and Tormey D. (1977): Perspectives in the treatment of breast cancer: 1976. Ann. intern. Med. 86:784–798

    Google Scholar 

Download references

Authors
  1. K. W. Brunner
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medizinische Klinik, Poliklinik der Universität, Albert-Schweitzer-Str. 33, 4400, Münster, Deutschland

    Th. Büchner , D. Urbanitz  & J. van de Loo ,  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Springer: Berlin Heidelberg

About this paper

Cite this paper

Brunner, K.W. (1985). Die internistische Therapie des metastasierenden Mammakarzinoms. In: Büchner, T., Urbanitz, D., van de Loo, J. (eds) Therapie des Mammakarzinoms. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70033-0_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-70033-0_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-13778-8

  • Online ISBN: 978-3-642-70033-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation